Merck’s Heplisav Gets FDA Clinical Hold
This article was originally published in The Pink Sheet Daily
Executive Summary
Phase III subject diagnosed with Wegener’s granulomatosis, a rare blood vessel inflammation.
You may also be interested in...
US FDA Tweaks IND Clinical Hold Policy As Number Of Holds Rises
Clinical holds by the US FDA have risen 36% since 2014.
Pfizer TLR-9 Adjuvant With Prevnar In HIV Patients Hints At Post-Wyeth Vaccine Opportunities
Danish academic trial has been looking at how Pfizer/Coley adjuvant can enhance effect of standard Wyeth Prevnar formulation.
Pfizer TLR-9 Adjuvant With Prevnar In HIV Patients Hints At Post-Wyeth Vaccine Opportunities
Danish academic trial has been looking at how Pfizer/Coley adjuvant can enhance effect of standard Wyeth Prevnar formulation.